SMARCB1 and schwannoma: An exhaustive molecular genetic analysis was performed in two schwannomas of the patient to identify mutations in the NF2 and SMARCB1 genes, including cDNA and DNA sequencing, MLPA, microsatellite multiplex PCR and SNP-array analyses, to clarify the molecular diagnostics.